Contact
Please use this form to send email to PR contact of this press release:
Project Alive Urges FDA to Prioritize Approvals for Life-Saving Rare Disease Treatments Fof RGX-121 Gene Therapy
TO:
Mike Mena
Project Alive
+1 310-913-0625